4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-19-012873
Options or other derivatives
- Chief Commercial Officer acquired 400,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kapur Anil · Chief Commercial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-07-12 | Grant or award : show line 1 in the form Options to purchase common stock | +400,000 | $0.23 | $92,800 | 400,000 | D |
Loading xslF345X03/ownership.xml…